• Home
  • Portfolio
  • Insights
  • About
  • Contact
Things to consider when designing a clinical trial involving children

Things to consider when designing a clinical trial involving children

by Barbara Van den Aarsen | May 22, 2025 | Blog

Clinical trials play a vital role in developing new treatments and medications. However, when children are involved, the process becomes significantly more complex. Children are considered a vulnerable population, requiring careful ethical, regulatory, and...
Challenges in Clinical Trials for Orphan Drugs

Challenges in Clinical Trials for Orphan Drugs

by Barbara Van den Aarsen | Jan 9, 2025 | Blog

The main challenges encountered during clinical trials include patient recruitment and retention, but also regulatory hurdles and methodological complexities need to be overcome. Drug repurposing is one of the possibilities used by Orfenix that aims to ease the...

Recent Posts

  • Aligning interests: how IP can make drug repurposing work for everyone
  • Guanabenz for Vanishing White Matter
  • Things to consider when designing a clinical trial involving children
  • Understanding pseudoxanthoma elasticum: Insights from Orfenix
  • Exclusive to be inclusive, the ethics of exclusivity

Recent Comments

No comments to show.

Contact us

Langegracht 70
2312NV Leiden
The Netherlands

+31(0)71 523 45 67
info@orfenix.com

 

Orfenix repurposes existing compounds to create sustainable and affordable therapies, focusing on accessible healthcare through innovative and collaborative efforts.

Do you want to collaborate? Let us know on investors@orfenix.com

 

  • Follow